Justin A Renz insider trades

Open-market stock purchases and sales by Justin A Renz, CFO at Zevra Therapeutics, Inc, from SEC Form 4 filings since Jan 15, 2010.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -98%.

Recent trades

DateStockTradeValue
Mar 18, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—

Companies traded

  • ZVRA Zevra Therapeutics, Inc: other filings, last Mar 18, 2026
  • ARDX Ardelyx, Inc: 1 buy, 26 sales, last Aug 21, 2025
  • KPTI Karyopharm Therapeutics Inc: 1 buy, 1 sale, last Jan 20, 2017
  • ZLCS Zalicus Inc: other filings, last Feb 10, 2014
  • CRXX Combinatorx, Inc: other filings, last Jan 15, 2010

Get free alerts when Justin A Renz files a new trade →